Key Highlights
- Zotefoams plc (LSE:ZTF) remains in focus in mid-October 2026 as its new Vietnam footwear foam plant moves towards trial production, which the company scheduled for October.
- First-half 2026 revenue rose 23% to £95.2 million and adjusted operating profit climbed 34% to £16.3 million, helped by the OKC acquisition.
- A collective consultation affecting more than 100 roles at the Croydon site could deliver around £4 million of annual savings if approved.
- The chief executive and chief financial officer recently added shares through the company's Share Incentive Plan at about 449p each.
- Footwear revenue fell 23% in the first half and is expected to remain under pressure into 2027, with recovery targeted from 2028.
Why Zotefoams Is Being Watched on 16 October 2026
Zotefoams plc (LSE:ZTF), the Croydon-headquartered maker of high-performance foams listed on the Main Market of the London Stock Exchange, continues to attract investor attention in October 2026 as several strands of its strategy converge. No single price-sensitive statement was published on Friday 16 October, but the stock remains in focus because the company had flagged October as the month in which trial production should begin at its new Vietnam footwear foam facility, a central part of its plan to relocate supply closer to customers in Asia.
That move has a direct counterpart in the UK. In September, the company's plan to consult on cutting more than 100 jobs at Croydon drew coverage in the local community, with production of footwear foam shifting overseas. For shareholders, the restructuring is a cost lever; for the business, it is a strategic repositioning of how the footwear segment is served.
Recent director dealing has added to the interest. Zotefoams disclosed that its chief executive and chief financial officer acquired shares at around 449p each under the company's Share Incentive Plan. While these are routine plan purchases rather than large discretionary buys, they show management participating at current levels.
Strong First Half Driven by OKC and Non-Footwear Markets
The investment case for Zotefoams (LSE:ZTF) rests heavily on the interim results released on 5 August 2026. For the six months to 30 June, group revenue rose 23% to £95.2 million from £77.4 million. Adjusted operating profit increased 34% to £16.3 million, and the operating margin improved by 130 basis points to 17.1%. The board lifted the interim dividend by 5.2% to 2.63p per share.
The acquisition of OKC, completed in November 2025, contributed £14.8 million of revenue in its first full half-year. Excluding OKC, organic revenue grew 4%, or 6% at constant currency. North America was a standout, with revenue up 29% to £18.7 million and the regional operating margin more than doubling to 17.6% from 8.3%. Asia revenue more than doubled to £2.9 million, albeit from a small base.
The weak spot was footwear. Revenue from this segment, which supplies foam used in high-performance running shoes, fell 23% to £28.5 million. Management expects footwear volumes and revenue to stay under pressure into 2027, with recovery anticipated from 2028 as the Vietnam operation ramps up.
Croydon Restructuring and the Asian Footprint
The proposed Croydon restructuring involves a collective consultation covering more than 100 employees. If implemented, the company expects annualised savings of around £4 million with a payback period of under a year, with most one-off costs falling in the second half of 2026. Alongside Vietnam, operations in South Korea were also expected to start towards the end of the year, broadening the group's manufacturing base in Asia.
Financial Position
Zotefoams entered 2026 with a new £90 million multi-currency revolving credit facility, replacing a previous £50 million facility. At the half-year, liquidity headroom stood at £50.2 million and net debt on a bank covenant basis was £39.1 million, equivalent to leverage of 0.98 times. That leaves room to fund the Asian expansion and restructuring costs without straining the balance sheet.
Full-year expectations were left unchanged at the interim stage. Market consensus before the results pointed to 2026 revenue of around £190.8 million and adjusted profit before tax of about £26.3 million, compared with £158.5 million and £21.2 million in 2025. Over the medium term, the company is targeting revenue above £230 million by 2029.
Sector and Market Context
Zotefoams (LSE:ZTF), a Main Market small cap, operates in specialty materials, supplying foams to aerospace, automotive, healthcare, construction and consumer markets as well as footwear. Its earlier trading update in May described robust demand, sending the shares higher at the time, and the company said it was monitoring instability in the Middle East and managing raw material cost changes. Broader UK small-cap sentiment, currency moves and the health of global consumer spending on premium sports footwear all influence how the shares trade.
Risks to Consider
Key risks include the timing and cost of the Vietnam ramp-up, prolonged weakness in footwear demand, concentration of footwear sales among a small number of major brands, integration of OKC, and execution of the Croydon restructuring, including employee relations. Raw material and energy price volatility could also pressure margins.
What Investors Are Watching Next
The next milestones are confirmation that Vietnam trial production is under way, the outcome of the Croydon consultation, and a year-end trading statement that shows whether Zotefoams can meet full-year expectations. Investors will also watch the footwear order book for any sign of stabilisation ahead of the targeted 2028 recovery.




_11_18_2026_14_55_02_703826.jpg)

Please wait processing your request...